Neuralgia Treatment Market Size and Growth Forecast for Businesses 2025–2029

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

#What Are The Current (2025) And Forecast (2029) Sizes Of The Neuralgia Treatment Market?

The neuralgia treatment market has experienced substantial growth in recent years. It is anticipated to increase from $2.3 billion in 2024 to $2.43 billion in 2025, achieving a compound annual growth rate (CAGR) of 5.7%. Factors contributing to this historical expansion include the rising prevalence of neuralgia, enhanced awareness of neuropathic pain, an increase in chronic pain conditions, the existence of high disposable income, and various government initiatives.

The neuralgia treatment market size is anticipated to experience robust expansion over the next few years. It is forecast to reach $3.13 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 6.5%. The projected growth during this period can be attributed to an aging population, the introduction of emerging therapies, an increasing prevalence of diabetes, and high healthcare expenditure. Significant trends in the forecast period encompass advancements in pain management, the availability of innovative products, the integration of digital health solutions, and the development of new drug delivery systems.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12921&type=smp

What Are The Main Drivers Boosting The Neuralgia Treatment Industry’s Expansion?

The increasing occurrence of chronic illnesses, including diabetes, is anticipated to fuel the expansion of the neuralgia treatment market in the future. These long-term conditions persist for at least a year, often requiring ongoing medical attention, limiting daily functions, or both. Diabetes, a chronic metabolic disorder, is marked by elevated levels of blood glucose or blood sugar. Treatment for neuralgia can address diabetic neuropathy, which refers to nerve damage frequently observed in individuals with diabetes. To illustrate, data from September 2023, released by the World Health Organization, a specialized United Nations agency based in Switzerland, indicated that 41 million deaths annually worldwide, accounting for 74% of all fatalities, were attributed to non-communicable diseases (NCDs) or chronic illnesses. Consequently, the growing prevalence of chronic diseases, such as diabetes, is a key driver for the growth of the neuralgia treatment market.

What Are The Key Segments In The Neuralgia Treatment Market?

The neuralgia treatmentmarket covered in this report is segmented –

1) By Treatment: Drug Based; Surgeries

2) By Indication: Diabetic Neuropathy; Intercostal Neuralgia; Occipital Neuralgia; Peripheral Neuralgia; Postherpetic Neuralgia

3) By Distribution channels: Drug Stores; Hospital Pharmacies; Online Pharmacies; Retail Pharmacies

4) By End-Use: Hospitals And Clinics; Ambulatory Surgery Centers; Other End-Users

Subsegments:

1) By Drug Based: Anticonvulsants; Antidepressants; Opioids; Topical Treatments; Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)

2) By Surgeries: Nerve Block Procedures; Decompression Surgery; Neurectomy; Spinal Cord Stimulation

How Are Trends Influencing The Neuralgia Treatment Market?

Leading companies active in the neuralgia treatment market are concentrating on developing innovative products and solutions to sustain their standing in the industry. For example, in April 2023, GlaxoSmithKline Pharmaceuticals Ltd., an India-based pharmaceutical firm, launched Shingrix in India. This product is recognized as the world’s first non-live and recombinant subunit vaccine. It is formulated to prevent shingles and post-herpetic neuralgia in adults aged 50 years and older, administered intramuscularly in two doses. Shingrix combines the antigen glycoprotein E with the adjuvant system AS01B to create a potent and lasting immunological response, helping to counteract the immune system’s natural decline with age. Clinical trials have indicated that it is 97% effective in preventing shingles in adults. Additionally, it effectively prevents post-herpetic neuralgia, a painful complication of shingles.

Which Industry Leaders Are Driving Innovation Across The Neuralgia Treatment Market?

Major companies operating in the neuralgia treatment market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Bayer AG, Novartis AG, Bristol-Myers Squibb Company, AstraZeneca PLC, Abbott Laboratories, GlaxoSmithKline PLC, Eli Lilly and Company, Gilead Sciences Inc., Teva Pharmaceutical Industries Ltd., Mylan N.V., Astellas Pharma Inc., Biogen Inc., Daiichi Sankyo Company Limited, Boehringer Ingelheim International GmbH, Sun Pharmaceutical Industries Limited, Horizon Therapeutics, Purdue Pharma, Dr. Reddy’s Laboratories, Cipla Limited, Hikma Pharmaceuticals PLC, Zydus Lifesciences Ltd., Lupin Limited, Mallinckrodt Pharmaceuticals, Glenmark Pharmaceuticals, Tonix Pharmaceuticals.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/neuralgia-treatment-global-market-report

Which Geographies Are Emerging As Strong Markets For The Neuralgia Treatment Industry?

North America was the largest region in the neuralgia treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in neuralgia treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Request A Customized Version Of The Neuralgia Treatment Market Report:

https://www.thebusinessresearchcompany.com/customise?id=12921&type=smp

Browse Through More Reports Similar to the Global Neuralgia Treatment Market 2025, By The Business Research Company

Generic Central Nervous System Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/generic-central-nervous-system-drugs-global-market-report

Nerve Repair And Regenerative Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/nerve-repair-and-regenerative-global-market-report

Central Nervous System Biomarkers Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/central-nervous-system-biomarkers-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795